| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $77.0M | — | -7.8% |
| Cost of Revenue | $11.1M | — | -6.6% |
| R&D Expense | $2.3M | — | -0.9% |
| SG&A Expense | $24.2M | — | +39.5% |
| Operating Income | -$1.1M | — | -106.5% |
| Pre-tax Income | -$492K | — | -102.8% |
| Income Tax | $62K | — | -94.0% |
| Net Income | -$573K | — | -164.4% |
| EPS (Basic) | -$0.23 | — | -153.5% |
| EPS (Diluted) | -$0.23 | — | -156.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $52.7M | -24.9% | -33.5% |
| Accounts Receivable | $4.6M | -19.6% | -47.7% |
| Current Assets | $111.8M | -15.1% | -26.9% |
| Total Assets | $201.9M | -7.5% | -15.7% |
| Current Liabilities | $229.1M | -2.2% | -7.7% |
| Total Liabilities | $428.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | -219.7% |
| Capital Expenditures | $473K | — | +951.1% |
| Investing Cash Flow | -$600K | — | -170.3% |
| Financing Cash Flow | -$14.8M | — | +26.8% |
| Free Cash Flow | -$2.5M | — | -250.9% |
| -6.2% |
| Stockholders' Equity | -$12.2M | -4.8% | +22.6% |